Literature DB >> 20376095

Disseminated coccidioidomycosis in a patient managed with adalimumab for Crohn's disease.

Sumeet S Mitter1, Ariss Derhovanessian, Joseph D Hillman, Daniel Z Uslan.   

Abstract

BACKGROUND: A 50-year-old man presented with a 2-3 month history of left lower quadrant abdominal pain, right periorbital headache, blurry vision, tinnitus, polydipsia, right elbow pain, and a 32 kg weight loss over the past year. He had a 34-year history of complicated Crohn's disease that was notable for surgical stricture repair and partial colectomy for bowel perforation. The patient was receiving mesalazine and 6-mercaptopurine and, 2 months before admission, had stopped a 4-month therapy course with the biologic agent adalimumab for treatment of Crohn's disease. INVESTIGATIONS: Physical examination, brain and elbow MRI scans, chest CT scan, routine blood analyses, assessment of coccidioidomycosis antibody levels, immunodiffusion and complement fixation studies in serum and cerebrospinal fluid, full-body technetium-99m nuclear bone scan, hematoxylin and eosin staining of resected tissue specimens. DIAGNOSIS: Disseminated coccidioidomycosis with meningeal, bone, soft tissue and pulmonary involvement. MANAGEMENT: The patient underwent treatment with amphotericin B liposomal complex and oral fluconazole and right elbow surgical debridement and irrigation. All immunosuppressive therapy was stopped.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20376095     DOI: 10.1038/nrgastro.2010.20

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  24 in total

Review 1.  Coccidioidomycosis.

Authors:  John N Galgiani; Neil M Ampel; Janis E Blair; Antonino Catanzaro; Royce H Johnson; David A Stevens; Paul L Williams
Journal:  Clin Infect Dis       Date:  2005-09-20       Impact factor: 9.079

Review 2.  Epidemiologic, clinical, and diagnostic aspects of coccidioidomycosis.

Authors:  Michael A Saubolle; Peter P McKellar; Den Sussland
Journal:  J Clin Microbiol       Date:  2006-11-15       Impact factor: 5.948

Review 3.  Preventing and treating biologic-associated opportunistic infections.

Authors:  Kevin L Winthrop; Tom Chiller
Journal:  Nat Rev Rheumatol       Date:  2009-07       Impact factor: 20.543

4.  Infections in patients with rheumatoid arthritis treated with biologic agents.

Authors:  Joachim Listing; Anja Strangfeld; Sonja Kary; Rolf Rau; Ulrich von Hinueber; Maria Stoyanova-Scholz; Erika Gromnica-Ihle; Christian Antoni; Peter Herzer; Jörn Kekow; Matthias Schneider; Angela Zink
Journal:  Arthritis Rheum       Date:  2005-11

5.  Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.

Authors:  Jean-Frédéric Colombel; William J Sandborn; Paul Rutgeerts; Robert Enns; Stephen B Hanauer; Remo Panaccione; Stefan Schreiber; Dan Byczkowski; Ju Li; Jeffrey D Kent; Paul F Pollack
Journal:  Gastroenterology       Date:  2006-11-29       Impact factor: 22.682

6.  Induction of tumor necrosis factor alpha by spherules of Coccidioides immitis.

Authors:  D C Slagle; R A Cox; U Kuruganti
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

7.  Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group.

Authors:  J N Galgiani; A Catanzaro; G A Cloud; R H Johnson; P L Williams; L F Mirels; F Nassar; J E Lutz; D A Stevens; P K Sharkey; V R Singh; R A Larsen; K L Delgado; C Flanigan; M G Rinaldi
Journal:  Ann Intern Med       Date:  2000-11-07       Impact factor: 25.391

Review 8.  Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Authors:  Tim Bongartz; Alex J Sutton; Michael J Sweeting; Iain Buchan; Eric L Matteson; Victor Montori
Journal:  JAMA       Date:  2006-05-17       Impact factor: 56.272

Review 9.  Coccidioidomycosis in solid organ transplantation.

Authors:  J E Blair; J L Logan
Journal:  Clin Infect Dis       Date:  2001-10-04       Impact factor: 9.079

10.  Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists.

Authors:  Laurie Bergstrom; David E Yocum; Neil M Ampel; Isidro Villanueva; Jeffrey Lisse; Oscar Gluck; John Tesser; James Posever; Margaret Miller; Julio Araujo; Dana M Kageyama; Martin Berry; Linda Karl; Christianne M Yung
Journal:  Arthritis Rheum       Date:  2004-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.